If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Exact Sciences Corporation EXAS has launched the Cancerguard test, a new multi-cancer early detection (MCED) blood test now offered as a laboratory-developed test (LDT) in the United States.

(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...

Dr. Tomasz Beer, MD, chief medical officer at Exact Sciences, joins HealthLeaders for a discussion on the clinical research behind Cancerguard tests and how they enable health systems to detect ...